Literature DB >> 3808473

Biphasic actions of L-DOPA on the release of endogenous dopamine via presynaptic receptors in rat striatal slices.

Y Misu, Y Goshima, T Kubo.   

Abstract

In rat striatal slices, 30 nM of L-DOPA increased the impulse (5 Hz)-evoked release of dopamine (DA), without increasing the spontaneous release and tissue content of DA. The minimum dose required to increase spontaneous DA release was 0.1 microM and the dose which led to an accumulation of DA was 100 microM. In the presence of NSD-1055, a DOPA-decarboxylase inhibitor, L-DOPA-induced increases in spontaneous DA release were prevented and L-DOPA produced dual actions on the evoked release of DA, a stereoselective propranolol-sensitive increase at 30 nM and a stereoselective sulpiride-sensitive decrease at 1 microM. L-DOPA produces dual presynaptic regulatory actions on DA release, via facilitatory beta-adrenoceptors at 30 nM and inhibitory DA receptors at 1 microM. The primary action of L-DOPA appears to be the facilitation of release of DA rather than the conversion to DA.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3808473     DOI: 10.1016/0304-3940(86)90079-0

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

1.  L-DOPA inhibits depolarization-induced [3H]GABA release in the dopamine-denervated globus pallidus of the rat: the effect is dopamine independent and mediated by D2-like receptors.

Authors:  I Silva; H Cortes; E Escartín; C Rangel; L Florán; D Erlij; J Aceves; B Florán
Journal:  J Neural Transm (Vienna)       Date:  2006-06-01       Impact factor: 3.575

2.  The effect of reserpine treatment in vivo upon L-dopa and amphetamine evoked dopamine and DOPAC efflux in vitro from the corpus striatum of male rats.

Authors:  D E Dluzen; B Liu
Journal:  J Neural Transm Gen Sect       Date:  1994

3.  Effects of L-DOPA on striatal iodine-123-FP-CIT binding and behavioral parameters in the rat.

Authors:  Susanne Nikolaus; Markus Beu; Hubertus Hautzel; Angelica M De Souza Silva; Christina Antke; Andreas Wirrwar; Joseph P Huston; Hans-Wilhelm Müller
Journal:  Nucl Med Commun       Date:  2013-12       Impact factor: 1.690

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.